BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

NeoGyn Release: Vulvar Pain: A Silent Female Epidemic


6/27/2012 11:15:51 AM

NEW YORK, June 26, 2012 /PRNewswire/ -- Vulvar pain is estimated to affect 14 million American women. Discomfort is incredibly common due to the sensitivity of vulvar skin and can generate symptoms such as pain, sensitivity to touch, itching, burning, redness, dryness, and even an inability to engage in sexual intercourse.

(Photo: http://photos.prnewswire.com/prnh/20120417/NY88908 )

Vulvar pain affects 9% of the female population in America, making it more prevalent than diabetes, depression and eating disorders among women. Despite these statistics, vulvar discomfort is unlike these health epidemics because it is rarely discussed publicly.

One of the main causes of vulvar discomfort is hormonal changes, which is why women going through menopause, undergoing breast cancer treatment or taking oral contraceptives are at a greater risk for developing vulvar pain. A decrease in estrogen levels is the known culprit in these cases, causing vulvar skin to become thin and easily irritated. Additionally, there are several vulvar conditions that are linked to vulvar pain, including vestibulodynia or vulvar vestibulitis syndrome, lichen sclerosus, and lichen planus.

To spread awareness for this condition NeoGyn® chooses to educate women on the pain itself as well as ways to find relief. NeoGyn Vulvar Soothing Cream helps to soothe and restore vulvar skin without the use of estrogen, parabens or anesthetics. Instead NeoGyn relies on a scientific formulation of cutaneous lysate, a novel ingredient discovered in Switzerland after years of wound healing. NeoGyn's goal is to provide knowledge to women and give them the encouragement they need to speak up about a pain that deserves to be discussed.

About Neogyn®:
Neogyn® Vulvar Soothing Cream is a cosmetic product to help soothe and relieve vulvar discomfort. Formulated with Cutaneous Lysate, a naturally balanced blend of proteins discovered in Switzerland, the product is non-greasy, fast absorbing and free of parabens, propylene glycol, color additives, fragrances and analgesics. Recommended by physicians and women's health professionals, Neogyn® has a unique, patent pending blend of naturally balanced proteins that help restore well-being and comfort with twice daily use over a period of at least 6 to 8 weeks.

RELATED LINKS
http://www.neogyn.us

SOURCE NeoGyn



Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES